BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: García-Colmenero L, González J, Sandoval J, Guillén Y, Diaz-Lagares A, Andrades E, Iglesias A, Nonell L, Pujol RM, Bigas A, Espinosa L, Gallardo F. Epigenetic Silencing of Tumor Suppressor miR-124 Directly Supports STAT3 Activation in Cutaneous T-Cell Lymphoma. Cells 2020;9:E2692. [PMID: 33333886 DOI: 10.3390/cells9122692] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 Kołkowski K, Trzeciak M, Sokołowska-Wojdyło M. Safety and Danger Considerations of Novel Treatments for Atopic Dermatitis in Context of Primary Cutaneous Lymphomas. Int J Mol Sci 2021;22:13388. [PMID: 34948183 DOI: 10.3390/ijms222413388] [Reference Citation Analysis]
2 Zhang P, Zhang M. Epigenetics in the Pathogenesis and Treatment of Cutaneous T-Cell Lymphoma. Front Oncol 2021;11:663961. [PMID: 34249700 DOI: 10.3389/fonc.2021.663961] [Reference Citation Analysis]
3 Gan L, Shi H, Zhang Y, Sun J, Chen H. Proteomic Screening and Verification of Biomarkers in Different Stages of Mycosis Fungoides: A pilot Study. Front Cell Dev Biol 2021;9:747017. [PMID: 34966737 DOI: 10.3389/fcell.2021.747017] [Reference Citation Analysis]